# MIPLYFFA

NDC: 72542-147
Generic name: arimoclomol citrate
Labeler / Manufacturer: Acer Therapeutics Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20240920

FDA application: NDA214927

## Active ingredients

- ARIMOCLOMOL CITRATE: 47 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72542-147"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72542-147
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5feffc0e-453d-47fa-91dd-38d4952309bc